|
1
|
Dean M, Fojo T and Bates S: Tumor stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
2
|
Hadnagy A, Gaboury L, Beaulieu R and
Balicki D: SP analysis may be used to identify cancer stem cell
populations. Exp Cell Res. 312:701–710. 2006. View Article : Google Scholar
|
|
3
|
Piccirillo SG and Vescovi AL: Brain tumor
stem cells: possibilities of new therapeutic strategies. Expert
Opin Biol Ther. 7:1129–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clarke MF, Morrison SJ, Wicha MS, et al:
Isolation and use of solid tumor stem cells. US Patent Application
119565. Filed December 28, 2002; issued April 21, 2011.
|
|
7
|
Suetsugu A, Nagaki M, Aoki H, et al:
Characterization of CD133+ hepatocellular carcinoma
cells as cancer stem/progenitor cells. Biochem Biophys Res Commun.
351:820–824. 2006.
|
|
8
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
9
|
Gong C, Liao H, Guo F, et al: Implication
of expression of Nanog in prostate cancer cells and their stem
cell. J Huazhong Univ Sci Technolog Med Sci. 32:242–246. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dubrovska A, Elliott J, Salamone RJ, et
al: CXCR4 expression in prostate cancer progenitor cells. PLoS One.
7:e312262012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan X, Liu S, Su F, et al: Effective
enrichment of prostate cancer stem cells from spheres in a
suspension culture system. Urol Oncol. 30:314–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu RQ, Wu JG, Zhou GC, et al: Sorting of
CD133(+) subset cells in human gastric cancer and the
identification of their tumor initiating cell-like properties.
Zhonghua Wei Chang Wai Ke Za Zhi. 15:174–179. 2012.(In
Chinese).
|
|
13
|
He JQ, Vu DM, Hunt G, et al: Human cardiac
stem cells isolated from atrial appendages stably express c-kit.
PLoS One. 6:e277192011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang B, Yoo N, Vu M, et al: Transforming
growth factor-beta can suppress tumorigenesis through effects on
the putative cancer stem or early progenitor cell and committed
progeny in a breast cancer xenograft model. Cancer Res.
67:8643–8652. 2007. View Article : Google Scholar
|
|
15
|
Richardson GD, Robson CN, Lang SH, et al:
CD133, a novel marker for human prostatic epithelial stem cells. J
Cell Sci. 117:3539–3545. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mittal S, Mifflin R and Powell DW: Cancer
stem cells: the other face of Janus. Am J Med Sci. 338:107–112.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scopelliti A, Cammareri P, Catalano V, et
al: Therapeutic implications of cancer initiating cells. Expert
Opin Biol Ther. 9:1005–1016. 2009. View Article : Google Scholar
|
|
18
|
Uchida N, Buck DW, He D, et al: Direct
isolation of human central nervous system stem cells. Proc Natl
Acad Sci. 97:14720–14725. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast
cancer cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005.PubMed/NCBI
|
|
20
|
Bao S, Wu Q, Li Z, et al: Targeting cancer
stem cells through L1CAM suppresses glioma growth. Cancer Res.
68:6043–6048. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Woodward WA, Chen MS, Behbod F, et al: On
mammary stem cells. J Cell Sci. 118:3585–3594. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rizzo S, Attand G and Hudson DL: Prostate
epithelial stem cells. Cell Prolif. 38:363–374. 2005. View Article : Google Scholar
|
|
23
|
Guo C, Liu H, Zhang BH, et al: Epcam,
CD44, and CD49f distinguish sphere-forming human prostate basal
cells from a subpopulation with predominant tubule initiation
capability. PLoS One. 7:e342192012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patrawala L, Calhoun T,
Schneider-Broussard R, et al: Highly purified CD44+
prostate cancer cells from xenograft human tumors are enriched in
tumorigenic and metastatic progenitor cells. Oncogene.
25:1696–1708. 2006.PubMed/NCBI
|
|
25
|
Vander Griend DJ, Karthaus WL, Dalrymple
S, et al: The role of CD133 in normal human prostate stem cells and
malignant cancer-initiating cells. Cancer Res. 68:9703–9711.
2008.PubMed/NCBI
|
|
26
|
Li H, Chen X, Calhoun-Davis T, Claypool K
and Tang DG: PC3 human prostate carcinoma cell holoclones contain
self-renewing tumor-initiating cells. Cancer Res. 68:1820–1825.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang K and Waxman DJ: PC3 prostate
tumor-initiating cells with molecular profile
FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis. Mol Cancer.
9:3192010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Diener KR, Need EF, Buchanan G, et al:
TGF-beta signalling and immunity in prostate tumourigenesis. Expert
Opin Ther Targets. 14:179–192. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li X, Wang Y, Sharif-Afshar AR, et al:
Urothelial transdifferentiation to prostate epithelia is mediated
by paracrine TGF-beta signaling. Differentiation. 77:95–102. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tai S, Sun Y, Squires JM, et al: PC3 is a
cell line characteristic of prostatic small cell carcinoma.
Prostate. 71:1668–1679. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeng Y, Kakehi Y, Nouh MA, et al: Gene
expression profiles of lysophosphatidic acid-related molecules in
the prostate: relevance to prostate cancer and benign hyperplasia.
Prostate. 69:283–292. 2009. View Article : Google Scholar : PubMed/NCBI
|
